證據文獻
| NO | 論文 | 登載期刊 | PM ID | 全文鏈接 | 中文鏈接 |
|---|---|---|---|---|---|
| 1 | 輔助免疫細胞療法與全身系統性療法結合治療實體瘤的療效 | Anticancer Research 42: 4179-4187 / 2022 | 35896218 | https://ar.iiarjournals.org/content/42/8/4179 | http://m.kbddc.com/laitian/results/22.html |
| 2 | 食管癌對免疫細胞療法和低劑量納武單抗聯合治療有反應 | Journal of Medical Case Reports 15, Article number: 191 / 2021 | 33827668 | https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z | http://m.kbddc.com/laitian/results/23.html |
| 3 | 免疫細胞療法治療晚期/復發性乳腺癌的預后因素 | Anticancer Research 41:4133-4141 / 2021 | 34281884 | https://ar.iiarjournals.org/content/41/8/4133.long | http://m.kbddc.com/laitian/results/1.html |
| 4 | 過繼性T細胞免疫治療對晚期胰腺癌患者免疫學指標及預后的影響 | CYTOTHERAPYFeb;23(2):137-145/2020 | 32907781 | https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6 | http://m.kbddc.com/laitian/results/2.html |
| 5 | 接受一線化療免疫治療的轉移性結直腸癌患者的免疫狀態變化 | Anticancer Research 40:4763-4771 / 2020 | 32727803 | https://ar.iiarjournals.org/content/40/8/4763.long | http://m.kbddc.com/laitian/results/3.html |
| 6 | 過繼免疫細胞治療子宮頸神經內分泌癌 | Anticancer Research 40:4741-4748 / 2020 | 32727800 | https://ar.iiarjournals.org/content/40/8/4763 | http://m.kbddc.com/laitian/results/4.html |
| 7 | 免疫細胞治療子宮內膜癌和宮頸癌預后因素的回顧性研究 | Anticancer Research 40:4729-4740 / 2020 | 32727799 | https://ar.iiarjournals.org/content/40/8/4729.long | http://m.kbddc.com/laitian/results/5.html |
| 8 | 適應性免疫細胞治療對晚期胃癌患者免疫細胞譜的影響 | Cancer Med 9(14):4907-4917 / 2020 | 32529780 | https://ar.iiarjournals.org/content/40/8/4729.long | http://m.kbddc.com/laitian/results/6.html |
| 9 | γδT細胞免疫治療實體瘤預后因素的研究 | CYTOTHERAPY Jun;22(6):329-336 / 2020 | 32303429 | https://pubmed.ncbi.nlm.nih.gov/32303429/ | http://m.kbddc.com/laitian/results/7.html |
| 10 | 免疫細胞聯合一線化療治療結直腸癌的預后因素：一項回顧性研究 | Anticancer Research 39: 4525-4532 / 2019 | 31366555 | https://pubmed.ncbi.nlm.nih.gov/31366555/ | http://m.kbddc.com/laitian/results/8.html |
| 11 | 免疫細胞治療胰腺癌患者的預后因素 | Anticancer Research 38 (7) 4353-4360 / 2018 | 29970573 | https://pubmed.ncbi.nlm.nih.gov/29970573/ | http://m.kbddc.com/laitian/results/9.html |
| 12 | 腫瘤內注射唑來膦酸鹽沖擊樹突狀細胞、靜脈過繼活化T淋巴細胞和吉西他濱聯合綜合免疫治療不可切除的局部晚期胰腺癌的I/II期臨床研究 | Oncotarget Dec5;9(2):2838-2847./2017 | 29416816 | https://pubmed.ncbi.nlm.nih.gov/29416816/ | http://m.kbddc.com/laitian/results/10.html |
| 13 | 全身靜脈過繼轉移自體淋巴因子激活的αβT細胞改善替莫唑胺誘導的膠質瘤患者淋巴細胞減少 | Anticancer Research Jul;37(7):3921-3932./2017 | 28668896 | https://pubmed.ncbi.nlm.nih.gov/28668896/ | http://m.kbddc.com/laitian/results/11.html |
| 14 | 過繼免疫聯合化療治療IV期結直腸癌的臨床研究（COMVI研究） | Anticancer Research Jul;37(7):3941-3946. / 2017 | 28668898 | https://pubmed.ncbi.nlm.nih.gov/28668898/ | http://m.kbddc.com/laitian/results/12.html |
| 15 | 過繼免疫細胞療法治療晚期胃癌的回顧性研究 | Anticancer Research Jul;37(7):3947-3954. / 2017 | 28668899 | https://pubmed.ncbi.nlm.nih.gov/28668899/ | http://m.kbddc.com/laitian/results/13.html |
| 16 | mRNA-EP制備的腫瘤血管靶向CAR-T細胞用于臨床研究的免疫學質量和性能 | Mol Ther Oncolytics.Nov 16;3:16024. / 2016 | 27909701 | https://pubmed.ncbi.nlm.nih.gov/27909701/ | http://m.kbddc.com/laitian/results/14.html |
| 17 | 活化αβT細胞過繼免疫化療治療IV期結直腸癌 | Anticancer Research Jul;36(7):3741-6. / 2016 | 27354648 | https://pubmed.ncbi.nlm.nih.gov/27354648/ | http://m.kbddc.com/laitian/results/15.html |
| 18 | WT1抗原在多種實體癌細胞中表達的免疫組織化學分析 | Anticancer Research 36(7):3715-3724 / 2016 | 27354645 | https://pubmed.ncbi.nlm.nih.gov/27354645/ | http://m.kbddc.com/laitian/results/16.html |
| 19 | 自體免疫細胞治療改善不同類型晚期癌癥患者的免疫功能受損 | Anticancer Research 36(7):3715-3724 / 2016 | 26168498 | https://pubmed.ncbi.nlm.nih.gov/26168498/ | http://m.kbddc.com/laitian/results/17.html |
| 20 | 免疫細胞治療在不同類型晚期癌癥患者中的前瞻性安全性評價 | Anticancer Research 35(8):4535-4543 / 2015 | 25075106 | https://pubmed.ncbi.nlm.nih.gov/25075106/ | http://m.kbddc.com/laitian/results/18.html |
| 21 | 在晚期癌癥患者中評估細胞免疫狀態受損和失衡，并通過過繼性T細胞免疫治療恢復T細胞免疫狀態 | International Immunopharmacology18(1):90-97. / 2014 | 24269583 | https://pubmed.ncbi.nlm.nih.gov/24269583/ | http://m.kbddc.com/laitian/results/19.html |
| 22 | 封閉流式電穿孔系統治療實體瘤的自體腫瘤溶解物樹突狀細胞疫苗免疫治療 | Anticancer Research 33(7):2971-6. / 2013 | 23780988 | https://pubmed.ncbi.nlm.nih.gov/23780988/ | http://m.kbddc.com/laitian/results/20.html |
| 23 | 晚期肺癌過繼性活化T淋巴細胞免疫治療中觀察到的生存期延長：一項多中心歷史性隊列研究的結果 | Cancer Immunology, Immunotherapy 61:1781-1790. / 2012 | 22422103 | https://pubmed.ncbi.nlm.nih.gov/22422103/ | http://m.kbddc.com/laitian/results/21.html |